ILF2 and Miyoshi myopathy: To test this hypothesis, we used a CRISPR/Cas9 library screening strategy to identify DNA repair genes whose loss of function could suppress MM cells’ capability to overcome resistance to ILF2 ASO–induced DNA damage.